UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:July 06,
Acorda Therapeutics (NASDAQ:ACOR)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Acorda Therapeutics Charts.
Acorda Therapeutics (NASDAQ:ACOR)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Acorda Therapeutics Charts.

Acorda Therapeutics Inc News

Acorda Therapeutics Announces Delisting from Nasdaq
Monday 15 April 2024 (2 weeks ago) • Business Wire
Acorda Therapeutics Announces Nasdaq Delisting Notification
Wednesday 3 April 2024 (3 weeks ago) • Business Wire
Acorda Therapeutics and Merz Announce Signing of “Stalking Horse” Asset Purchase Agreement
Monday 1 April 2024 (4 weeks ago) • Business Wire
Acorda Cancels Q4 and Year End 2023 Earnings Conference Call Scheduled for April 1, 2024
Monday 1 April 2024 (4 weeks ago) • Business Wire
Acorda Fourth Quarter/Year End 2023 Update: Webcast/Conference Call Scheduled for April 1, 2024
Monday 25 March 2024 (1 month ago) • Business Wire
Form 8-K - Current report
Thursday 11 January 2024 (4 months ago) • Edgar (US Regulatory)
Acorda Therapeutics to Regain Global Commercialization Rights to FAMPYRA® by January 2025
Thursday 11 January 2024 (4 months ago) • Business Wire
Form 8-K - Current report
Friday 1 December 2023 (5 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Monday 13 November 2023 (5 months ago) • Edgar (US Regulatory)
Acorda Therapeutics Reports Third Quarter 2023 Financial Results
Monday 13 November 2023 (5 months ago) • Business Wire
Acorda Third Quarter 2023 Update: Webcast/Conference Call Scheduled for November 13, 2023
Monday 6 November 2023 (6 months ago) • Business Wire
Acorda Therapeutics Announces Biopas Laboratories Submission to Regulatory Agencies in Six Latin American Countries for Approval of INBRIJA®
Monday 6 November 2023 (6 months ago) • Business Wire

More Acorda Therapeutics Inc News Articles